HISTOCHEMICAL DISTRIBUTION OF CA-125 AS A PROGNOSTIC INDICATOR IN PATIENTS WITH SEROUS OVARIAN-CANCER

被引:3
作者
BICHEL, P
JAKOBSEN, A
ORNTOFT, TF
机构
[1] AARHUS UNIV, AARHUS KOMMUNE HOSP, INST PATHOL, DEPT CLIN CHEM, DK-8000 AARHUS, DENMARK
[2] VEJLE CENT HOSP, INST PATHOL, AARHUS, DENMARK
[3] DANISH CANC SOC, DEPT EXPTL CLIN ONCOL, AARHUS, DENMARK
关键词
CA-125; HISTOCHEMICAL DISTRIBUTION; OVARY CARCINOMA; PROGNOSIS;
D O I
10.1111/j.1525-1438.1991.tb00040.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The study comprises 66 patients with stage Ill and IV serous ovarian carcinoma While the percentage of CA-125 positive cells and the staining intensity showed no correlation to patient survival, the pattern of CA-125 distribution, membranous versus cytoplasmic, was significantly correlated to survival. In accordance with other observations on switching of the antigen reaction f rom membrane to cytoplasm with increasing grade of atypia or malignancy, patients with membrane positive CA-125 tumors had a significantly better prognosis than did patients with CA-125 in the cytoplasm. Furthermore, there was excellent agreement between, on the one hand, the binding pattern of CA-125 and, on the other, the ploidy of the tumor cells and the HGI histopathologic grading index, both previously shown to be of prognostic significance.
引用
收藏
页码:199 / 204
页数:6
相关论文
共 50 条
  • [21] Preoperative CA-125 Values as a Predictive Factor for the Postoperative Outcome in Primary Serous Ovarian Cancer
    Muallem, Mustafa Zelal
    Parashkevova, Asya
    Almuheimid, Jumana
    Richter, Rolf
    Diab, Yasser
    Braicu, Elena Ioana
    Sehouli, Jalid
    ANTICANCER RESEARCH, 2017, 37 (06) : 3157 - 3161
  • [22] TUMOR-MARKER CA-125 LEVELS IN STAGE-I EPITHELIAL OVARIAN-CANCER
    NAGELE, F
    VAVRA, N
    KURZ, C
    SEVELDA, P
    WIENER KLINISCHE WOCHENSCHRIFT, 1993, 105 (20) : 585 - 588
  • [23] A HUMAN MOUSE CHIMERIC MONOCLONAL-ANTIBODY AGAINST CA-125 FOR RADIOIMMUNOIMAGING OF OVARIAN-CANCER
    KOBAYASHI, H
    SAKAHARA, H
    SAGA, T
    HOSONO, M
    SHIRATO, M
    KANDA, H
    ISHIBASHI, K
    WATANABE, T
    ENDO, K
    ISHIWATA, I
    KONISHI, J
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1993, 37 (03) : 143 - 149
  • [24] FALSE CHANGES IN CA-125 LEVELS IN OVARIAN-CANCER PATIENTS AFTER INFUSION OF OC125 FRAGMENTS FOR DIAGNOSTIC AND THERAPEUTIC PURPOSE
    REINSBERG, J
    WAGNER, U
    KREBS, D
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1994, 255 (01) : 9 - 18
  • [25] Effects of paclitaxel on CA-125 serum levels in ovarian cancer patients
    Paulsen, T
    Marth, C
    Kærn, J
    Nustad, K
    Kristensen, GB
    Tropé, C
    GYNECOLOGIC ONCOLOGY, 2000, 76 (03) : 326 - 330
  • [26] The "real-life" variability of CA-125 in ovarian cancer patients
    Tso, Elisa
    Elson, Paul
    VanLente, Fred
    Markman, Maurie
    GYNECOLOGIC ONCOLOGY, 2006, 103 (01) : 141 - 144
  • [27] THE PROGNOSTIC-SIGNIFICANCE OF CA-125 HALF-LIFE IN PATIENTS WITH OVARIAN-CANCER WHO HAVE RECEIVED PRIMARY CHEMOTHERAPY AFTER SURGICAL CYTOREDUCTION
    HUNTER, VJ
    DALY, L
    HELMS, M
    SOPER, JT
    BERCHUCK, A
    CLARKEPEARSON, DL
    BAST, RC
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (04) : 1164 - 1167
  • [28] MUCIN-LIKE CARCINOMA-ASSOCIATED ANTIGEN AND CA-125 IN EVALUATION OF CHEMOTHERAPY RESULTS IN OVARIAN-CANCER PATIENTS
    MERIMSKY, O
    HAREUVENI, M
    INBAR, M
    LIMOR, R
    WITENBERG, B
    CHAITCHIK, S
    DIAGNOSTIC ONCOLOGY, 1993, 3 (03): : 117 - 120
  • [29] Nadir CA-125 Level Is an Independent Prognostic Factor in Advanced Epithelial Ovarian Cancer
    Kang, Sokbom
    Seo, Sang-Soo
    Park, Sang-Yoon
    JOURNAL OF SURGICAL ONCOLOGY, 2009, 100 (03) : 244 - 247
  • [30] Novel fluoroimmunoassay for ovarian cancer biomarker CA-125
    Sok, Davin
    Clarizia, Lisa-Jo A.
    Farris, Leslie R.
    McDonald, Melisenda J.
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2009, 393 (05) : 1521 - 1523